entertainment -WSS

entertainment

author：fashion 2025-09-29 21:24:21 - browse：25

Rod Nathan, Ali Urman, and Patrick Nosker on the 2024 Breakthrough Summit East stage. — From left, Rod Nathan, portfolio manager and partner of J. Goldman & Co.; ARK Invest senior analyst Ali Urman; and Patrick Nosker, director of research and partner at Affinity Asset Advisors, discuss biotech investment opportunities at the 2024 STAT Breakthrough Summit East. STAT

Following a blockbuster year of dealmaking and a recent uptick in biotech stocks, top investors see more good news on the horizon.

Driving the momentum? Economics 101.

Biotechs rely on borrowing capital, which is a more tenuous task when interest rates are high. But interest rates have most likely peaked, with Federal Reserve officials signaling earlier this week they expected to make three cuts this year. For public biotechnology startups that have been battered by the market in recent years, this is a very good thing, Rod Nathan, portfolio manager and partner of J. Goldman & Co., said on a panel at STAT’s Breakthrough Summit East in New York on Thursday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： To spot an incipient stroke, tiny brain probe acts ‘like a microscope’

hotspot

WSS

Eli Lilly to acquire Versanis in heated race for weight loss drugs

Congress likely to miss an opportunity to fix drug shortages issue

As H5N1 spreads in cows, experts warn against drinking raw milk

Abbott's new stent may help patients with peripheral artery disease

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Galapagos to make CAR

focus

entertainment

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

The United States must get value

Wildfire smoke exposes gaps in outdoor worker protections

Does aspartame cause cancer? What new WHO guidance says

Walensky prepares to leave CDC — and Congress — behind

Congress: Eradicate hepatitis C and reduce the deficit

Apple is now the first public company to be valued at $3 trillion

Grail faces three suits alleging harassment, retaliation

Medicare details structure of new drug price negotiation program

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

leisure time

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Global childhood vaccinations edge closer to pre

Europe sees delivery challenges ahead on Alzheimer's therapies

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Congress likely to miss an opportunity to fix drug shortages issue

focus

hotspot

focus

knowledge